The pituitary adrenal axis

Frontiers of Hormone Research

Volumn 24, Issue , 1999, Pages 110-130

  Newell Price, John ^a   Trainer, Peter J ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249101419     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061010     Document Type: Article

References (107)

1. Plumpton FS, Besser GM: The adrenocortical response to surgery and insulin-induced hypoglycaemia in corticosteroid-treated and normal subjects. Br J Surg 1969;56:216-219.
2. Van den Berghe G, de Zegher F, Bouillon R: Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-1834.
3. Norbiato G, Bevilacqua M, Vago T, Baldi G, Chebat E, Bertora P, Moroni M, Galli M, Oldenburg N: Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:608-613.
4. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY: Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993;151:3460-3466.
5. Molijn GJ, Koper JW, van Uffelen CJ, de Jong FH, Brinkmann AO, Bruining HA, Lamberts SW: Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol (Oxf) 1995;43:197-203.
6. Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R, Leicester R, Ross RJ: Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol (Oxf) 1992;37:542-551.
7. Cunnah D, Jessop DS, Besser GM, Rees LH: Measurement of circulating corticotrophin-releasing factor in man. J Endocrinol 1987;113:123-131.
8. Linton EA, McLean C, Nieuwenhuyzen Kruseman AC, Tilders FJ, Van der Veen EA, Lowry PJ: Direct measurement of human plasma corticotropin-releasing hormone by 'two-site' immunoradiometric assay. J Clin Endocrinol Metab 1987;64:1047-1053.
9. Giuffre KA, Udelsman R, Listwak S, Chrousos GP: Effects of immune neutralization of corticotropin-releasing hormone, adrenocorticotropin, and beta-endorphin in the surgically stressed rat. Endocrinology 1988;122:306-310.
10. Balard PL, Baxter JD, Rousseau GG (eds): Glucocorticoid Hormone Action. Delivery and Transport of Glucocorticoids to Target Cells. New York, Springer, 1979.
11. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen, TM, Glass CK, Rosenfeld MG: Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998;279:703-707.
12. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997;90:569-580.
13. Fisher GA, Anderson RL, Hahn GM: Glucocorticoid-induced heat resistance in mammalian cells. J Cell Physiol 1986;128:127-132.
14. Udelsman R, Blake MJ, Holbrook NJ: Molecular response to surgical stress: Specific and simultaneous heat shock protein induction in the adrenal cortex, aorta, and vena cava. Surgery 1991;110:1125-1131.
15. Blake MJ, Udelsman R, Feulner GJ, Norton DD, Holbrook NJ: Stress-induced heat shock protein 70 expression in adrenal cortex: An adrenocorticotropic hormone-sensitive, age-dependent response. Proc Natl Acad Sci USA 1991;88:9873-9877.
16. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
17. Munck A, Naray-Fejes-Toth A: Glucocorticoids and stress: Permissive and suppressive actions. Ann NY Acad Sci 1994;746:115-130.
18. 2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 1990;265:12745-12748.
19. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ: Tumor necrosis factor-alpha and interleukin-1-beta enhance the cortisone/cortisol shuttle. J Exp Med 1997;186:189-198.
20. 2 activity in rats. J Clin Invest 1993;92:1974-1980.
21. O'Banion MK, Winn VD, Young DA: cDNA cloning and functional activity of a glucocorticoidregulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89:4888-4892.
22. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E: Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 1992;89:217-221.
23. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
24. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-654.
25. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W: Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987;238:522-524.
26. Uehara A, Gottschall PE, Dahl RR, Arimura A: Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin-releasing factor. Endocrinology 1987;121:1580-1582.
27. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991;128:37-44.
28. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H: Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988;155:1459-1463.
29. Perlstein RS, Mougey EH, Jackson WE, Neta R: Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res 1991;10:141-146.
30. van Gool J, van Vugt H, Helle M, Aarden LA: The relation among stress, adrenalin, interleukin-6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990;57:200-210.
31. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993;132:946-952.
32. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamicpituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690-1694.
33. Fischer CP, Bode BP, Takahashi K, Tanabe KK, Souba WW: Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport. Ann Surg 1996;223:610-618.
34. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE: Glucocorticoid therapy for immunemediated diseases: Basic and clinical correlates. Ann Intern Med 1993;119:1198-1208.
35. Barton BE: The biological effects of interleukin-6. Med Res Rev 1996;16:87-109.
36. Barton BE, Jackson JV: Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993;61:1496-1499.
37. Bernier J, Jobin N, Emptoz-Bonneton A, Pugeat MM, Garrel DR: Decreased corticosteroid-binding globulin in burn patients: Relationship with interleukin-6 and fat in nutritional support. Crit Care Med 1998;26:452-460.
38. Doellner H, Arntzen KJ, Haereid PE, Aag S, Austgulen R: Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr 1998;132:295-299.
39. Abrahamsson J, Pahlman M, Mellander L: Interleukin-6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatr 1997;86:1059-1064.
40. Brown EA, Dare HA, Marsh CB, Wewers MD: The combination of endotoxin and dexamethasone induces type II interleukin-1 receptor in monocytes: Acomparison to interleukin-1-beta and interleukin-1 receptor antagonist. Cytokine 1996;8:828-836.
41. Molijn GJ, Spek JJ, van Uffelen JC, de Jong FH, Brinkmann AO, Bruining HA, Lamberts SW, Koper JW: Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995;80:1799-1803.
42. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP: Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm in cortisol and leptin secretion. J Clin Endocrinol Metab 1998;83:280-283.
43. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW: Human leptin levels are pulsatile and inversely related to pituitaryadrenal function. Nat Med 1997;3:575-579.
44. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK: Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997;82:1635-1637.
45. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC, Alvord WG, Smith JW Jr, Gause BL, Kopp WC: Interleukin-1-alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997;82:3084-3086.
46. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ: Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996;93:14564-14568.
47. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901.
48. Trainer PJ, Eastment C, Grossman AB,Wheeler MJ, Perry L, Besser GM: The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome. Clin Endocrinol (Oxf) 1993;39:441-443.
49. Newell-Price JDC, Trainer PJ, Besser GM, Grossman AB: The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-672.
50. Hume DM, Bell CC, Bartter F: Direct measurement of adrenal secretion during operative trauma and convalescence. Surgery 1962;52:174-187.
51. Cooper CE, Nelson DH: ACTH levels in plasma in preoperative and surgically stressed patients. J Clin Invest 1962;41:1599-1605.
52. Johnston IDA: The endocrine response to trauma. Adv Clin Chem 1972;15:255-285.
53. Gill GV, Prudhoe K, Cook DB, Latner AL: Effect of surgical trauma on plasma concentrations of cyclic AMP and cortisol. Br J Surg 1975;62:441-443.
54. Chopra MP, Thadani U, Aber CP, Portal RW, Parkes J: Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br Heart J 1972;34:992-997.
55. Bailey RR, Abernethy MH, Beaven DW: Adrenocortical response to the stress of an acutemyocardial infarction. Lancet 1967;i:970-973.
56. Jurney TH, Cockrell JL Jr, Lindberg JS, Lamiell JM, Wade CE: Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest 1987;92:292-295.
57. Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, Kloppenborg PW: Adrenocortical function: An indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 1992;18:93-96.
58. Drucker D, Shandling M: Variable adrenocortical function in acute medical illness. Crit Care Med 1985;13:477-479.
59. Reincke M, Allolio B, Wurth G, Winkelmann W: The hypothalamic-pituitary-adrenal axis in critical illness: Response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993;77:151-156.
60. Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, Fletcher JR: Hormonal responses to graded surgical stress. Arch Intern Med 1987;147:1273-1278.
61. Harris MJ, Baker RT, McRoberts JW, Mohler JL: The adrenal response to trauma, operation and cosyntropin stimulation. Surg Gynecol Obstet 1990;170:513-516.
62. Aun F, McIntosh TK, Lee A, Egdahl RH: The effects of surgery on the circadian rhythms of cortisol. Int Surg 1984;69:101-105.
63. Naito Y, Fukata J, Tamai S, Seo N, Nakai Y, Mori K, Imura H: Biphasic changes in hypothalamopituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab 1991;73:111-117.
64. Penhoat A, Jaillard C, Saez JM: Corticotropin positively regulates its own receptors and cA MP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 1989;86:4978-4981.
65. Vermes I, Beishuizen A, Hampsink RM, Haanen C: Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995;80:1238-1242.
66. Fink G, Dow RC, Casley D, Johnston CI, Bennie J, Carroll S, Dick H: Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid-negative feedback in the rat. J Endocrinol 1992;135:37-43.
67. Fink G, Dow RC, Casley D, Johnston CI, Lim AT, Copolov DL, Bennie J, Carroll S, Dick H: Atrial natriuretic peptide is a physiological inhibitor of ACTH release: Evidence from immunoneutralization in vivo. J Endocrinol 1991;131:R9-R12.
68. Kellner M, Wiedemann K, Holsboer F: Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 1992;50:1835-1842.
69. Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM, Grossman A: Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. J Endocrinol 1991;131:163-167.
70. Hinson JP, Vinson GP, Kapas S, Teja R: The role of endothelin in the control of adrenocortical function: Stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol 1991;128:275-280.
71. Parker CR Jr, Baxter CR: Divergence in adrenal steroid secretory pattern after thermal injury in adult patients. J Trauma 1985;25:508-510.
72. Lephart ED, Baxter CR, Parker CR Jr: Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 1987;64:842-848.
73. Schein RM, Sprung CL, Marcial E, Napolitano L, Chernow B: Plasma cortisol levels in patients with septic shock. Crit Care Med 1990;18:259-263.
74. Voerman HJ, Groeneveld AB, de Boer H, Strack van Schijndel RJ, Nauta JP, van der Veen EA, Thijs LG: Time course and variability of the endocrine and metabolic response to severe sepsis. Surgery 1993;114:951-959.
75. Voerman HJ, Stehouwer CD, van Kamp GJ, Strack van Schijndel RJ, Groeneveld AB, Thijs LG: Plasma endothelin levels are increased during septic shock. Crit Care Med 1992;20:1097-1101.
76. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991;33:222-227.
77. Zipser RD, Davenport MW, Martin KL, Tuck ML, Warner NE, Swinney RR, Davis CL, Horton R: Hyperreninemic hypoaldosteronism in the critically ill: A new entity. J Clin Endocrinol Metab 1981;53:867-873.
78. Davenport MW, Zipser RD: Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient. Arch Intern Med 1983;143:735-737.
79. Findling JW, Waters VO, Raff H: The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 1987;64:592-595.
80. Raff H, Findling JW: Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med 1990;18:915-920.
81. Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH: 11-Beta-hydroxysteroid dehydrogenase activity in Cushing's syndrome: Explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1995;80:3617-3620.
82. Carey RM, Thorner MO, Ortt EM: Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest 1980;66:10-18.
83. Beck FW, Sowers JR, Sicca D, Welch BG: Absent aldosterone response to metoclopramide in patients with high spinal cord transection: Evidence that metoclopramide stimulates aldosterone secretion through central pathways. Life Sci 1985;36:2435-2444.
84. Anderson JV, Struthers AD, Payne NN, Slater JD, Bloom SR: Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci (Colch) 1986;70:507-512.
85. Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985;60:947-952.
86. Drucker D, McLaughlin J: Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986;14:789-791.
87. Wade CE, Lindberg JS, Cockrell JL, Lamiell JM, Hunt MM, Ducey J, Jurney TH: Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab 1988;67:223-227.
88. Suzuki T, Suzuki N, Daynes RA, Engleman EG: Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991;61:202-211.
89. Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P: Dehydroepiandrosterone sulphate in critical illness: Effect of dopamine. Clin Endocrinol (Oxf) 1995;43:457-463.
90. Sibbald WJ, Short A, Cohen MP, Wilson RF: Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977;186:29-33.
91. McKee JI, Finlay WE: Cortisol replacement in severely stressed patients (letter). Lancet 1983;i:484
92. Finlay WE, McKee JI: Serum cortisol levels in severely stressed patients (letter). Lancet 1982;i:1414-1415.
93. Baldwin WA, Allo M: Occult hypoadrenalism in critically ill patients. Arch Surg 1993;128:673-676.
94. Watt I, Ledingham IM: Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984;39:973-981.
95. Ledingham IM, Watt I: Influence of sedation on mortality in critically ill multiple trauma patients (letter). Lancet 1983;i:1270
96. Allolio B, Dorr H, Stuttmann R, Knorr D, Engelhardt D, Winkelmann W: Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol (Oxf) 1985;22:281-286.
97. Allolio B, Stuttmann R, Fischer H, Leonhard W, Winkelmann W: Long-term etomidate and adrenocortical suppression (letter). Lancet 1983;ii:626
98. Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B: Infusion of low dose etomidate: Correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990;70:1426-1430.
99. Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM: Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 1998;83:3542-3544.
100. Udelsman R, Chrousos GP: Hormonal responses to surgical stress. Adv Exp Med Biol 1988;245:265-272.
101. Udelsman R, Ramp J, Gallucci WT, Gordon A, Lipford E, Norton JA, Loriaux DL, Chrousos GP: Adaptation during surgical stress. A re-evaluation of the role of glucocorticoids. J Clin Invest 1986;77:1377-1381.
102. Hinshaw LB, Beller BK, Chang AC, Passey RB, Lahti RA, Flournoy DJ, Lane MM, Archer LT: Effects of prior administration of steroids upon recovery from lethal sepsis. Surg Gynecol Obstet 1986;163:335-344.
103. Schuler JJ, Erve PR, Schumer W: Glucocorticoid effect on hepatic carbohydrate metabolism in the endotoxin-shocked monkey. Ann Surg 1976;183:345-354.
104. Schumer W: Steroids in the treatment of clinical septic shock. Ann Surg 1976;184:333-341.
105. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M: The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311:1137-1143.
106. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T: Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med 1982;306:313-319.
107. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650.